Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11057 - 11064 of 11616 results
PRETZEL CRISPS: The Importance of Evaluating A Trademark's Strength
February 22, 2012| Blog| Viewpoint
CMS Proposed Rules for Reporting AMP and Best Price May Have Impact Beyond Medicaid Drug Rebates
February 22, 2012| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Reform Update on February 20, 2012
February 21, 2012| Blog| Viewpoint
FCC Adopts Rules Requiring Written Consent for Telemarketing “Robocalls”
February 17, 2012| Blog| Viewpoint
LINSANITY: The Trademark
February 16, 2012| Blog| Viewpoint
CMS Publishes Proposed Rule on Return of Medicare and Medicaid Overpayments
February 16, 2012| Blog| Viewpoint
District Court Allows Trial on Whether a Below Cost but Competitively Bid Arrangement Can Lead to a Kickback Violation
February 16, 2012| Blog| Viewpoint
Employee is Not "Substantially Limited" Under the ADA When He is Able to Work a 40-Hour Week But No Overtime.
February 15, 2012| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.